Lobe Sciences Statistics
Total Valuation
Lobe Sciences has a market cap or net worth of 4.95 million. The enterprise value is 6.50 million.
| Market Cap | 4.95M |
| Enterprise Value | 6.50M |
Important Dates
The next estimated earnings date is Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 192.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +61.16% |
| Shares Change (QoQ) | +7.29% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 64.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.97 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -131.58% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 101.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Lobe Sciences has paid 22,867 in taxes.
| Income Tax | 22,867 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.57% in the last 52 weeks. The beta is 1.99, so Lobe Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 1.99 |
| 52-Week Price Change | +62.57% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 49.93 |
| Average Volume (20 Days) | 67,850 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -10,670 |
| Operating Income | -1.57M |
| Pretax Income | -3.28M |
| Net Income | -3.30M |
| EBITDA | -1.53M |
| EBIT | -1.57M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 30,687 in cash and 1.49 million in debt, giving a net cash position of -1.46 million.
| Cash & Cash Equivalents | 30,687 |
| Total Debt | 1.49M |
| Net Cash | -1.46M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2.59M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.55M |
Cash Flow
| Operating Cash Flow | -655,899 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Lobe Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.16% |
| Shareholder Yield | n/a |
| Earnings Yield | -66.62% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 10, 2022. It was a reverse split with a ratio of 0.1666667.
| Last Split Date | Jun 10, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1666667 |
Scores
Lobe Sciences has an Altman Z-Score of -1392.95 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1392.95 |
| Piotroski F-Score | 1 |